By
Brenton Flynn and David Williamson
|
More Articles
December 20, 2012
|
Citron Research, a firm known for its bearish calls on a variety of stocks, is getting bored of the little guys. This week, it's gone after a giant. Its report titled, "Has the Halo Been Broken on Intuitive Surgical?" has many Intuitive Surgical (NASDAQ: ISRG ) investors panicking. It's easy to see why. The report calls for a $350 price target "for now," and $250 over the next 18 months. In this video, Motley Fool health care bureau chief Brenton Flynn takes a longer look at Intuitive and its business to try and tease out the truth about whether it's really time to abandon your position in this stock or whether the company is stronger than Mr. Left thinks.
More Expert Advice from The Motley Fool The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock in our brand-new free report: "
The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just
click here to access the report and find out the name of this under-the-radar company.